Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System

Lalitha Belur, Kelly M. Podetz-Pedersen, Brent S. Sorenson, Alice H. Hsu, Josh B. Parker, Cathy S Carlson, Daniel A Saltzman, S. Ramakrishnan, R S Mc Ivor

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Metastatic colon cancer is one of the leading causes of cancer-related death worldwide, with disease progression and metastatic spread being closely associated with angiogenesis. We investigated whether an antiangiogenic gene transfer approach using the Sleeping Beauty (SB) transposon system could be used to inhibit growth of colorectal tumors metastatic to the liver.Results: Liver CT26 tumor-bearing mice were hydrodynamically injected with different doses of a plasmid containing a transposon encoding an angiostatin-endostatin fusion gene (Statin AE) along with varying amounts of SB transposase-encoding plasmid. Animals that were injected with a low dose (10 μg) of Statin AE transposon plasmid showed a significant decrease in tumor formation only when co-injected with SB transposase-encoding plasmid, while for animals injected with a higher dose (25 μg) of Statin AE transposon, co-injection of SB transposase-encoding plasmid did not significantly affect tumor load. For animals injected with 10 μg Statin AE transposon plasmid, the number of tumor nodules was inversely proportional to the amount of co-injected SB plasmid. Suppression of metastases was further evident in histological analyses, in which untreated animals showed higher levels of tumor cell proliferation and tumor vascularization than animals treated with low dose transposon plasmid.Conclusion: These results demonstrate that hepatic colorectal metastases can be reduced using antiangiogenic transposons, and provide evidence for the importance of the transposition process in mediating suppression of these tumors.

Original languageEnglish (US)
Article number14
JournalMolecular Cancer
Volume10
DOIs
StatePublished - Feb 10 2011

Fingerprint

Beauty
Colorectal Neoplasms
Plasmids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Liver
Transposases
Neoplasms
Angiostatins
Endostatins
Neoplasm Metastasis
Inhibition (Psychology)
Gene Fusion
Tumor Burden
Colonic Neoplasms
Disease Progression
Cell Proliferation
Injections
Growth

Cite this

Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System. / Belur, Lalitha; Podetz-Pedersen, Kelly M.; Sorenson, Brent S.; Hsu, Alice H.; Parker, Josh B.; Carlson, Cathy S; Saltzman, Daniel A; Ramakrishnan, S.; Mc Ivor, R S.

In: Molecular Cancer, Vol. 10, 14, 10.02.2011.

Research output: Contribution to journalArticle

@article{32efb73704c549bcad751a81829ce73d,
title = "Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System",
abstract = "Background: Metastatic colon cancer is one of the leading causes of cancer-related death worldwide, with disease progression and metastatic spread being closely associated with angiogenesis. We investigated whether an antiangiogenic gene transfer approach using the Sleeping Beauty (SB) transposon system could be used to inhibit growth of colorectal tumors metastatic to the liver.Results: Liver CT26 tumor-bearing mice were hydrodynamically injected with different doses of a plasmid containing a transposon encoding an angiostatin-endostatin fusion gene (Statin AE) along with varying amounts of SB transposase-encoding plasmid. Animals that were injected with a low dose (10 μg) of Statin AE transposon plasmid showed a significant decrease in tumor formation only when co-injected with SB transposase-encoding plasmid, while for animals injected with a higher dose (25 μg) of Statin AE transposon, co-injection of SB transposase-encoding plasmid did not significantly affect tumor load. For animals injected with 10 μg Statin AE transposon plasmid, the number of tumor nodules was inversely proportional to the amount of co-injected SB plasmid. Suppression of metastases was further evident in histological analyses, in which untreated animals showed higher levels of tumor cell proliferation and tumor vascularization than animals treated with low dose transposon plasmid.Conclusion: These results demonstrate that hepatic colorectal metastases can be reduced using antiangiogenic transposons, and provide evidence for the importance of the transposition process in mediating suppression of these tumors.",
author = "Lalitha Belur and Podetz-Pedersen, {Kelly M.} and Sorenson, {Brent S.} and Hsu, {Alice H.} and Parker, {Josh B.} and Carlson, {Cathy S} and Saltzman, {Daniel A} and S. Ramakrishnan and {Mc Ivor}, {R S}",
year = "2011",
month = "2",
day = "10",
doi = "10.1186/1476-4598-10-14",
language = "English (US)",
volume = "10",
journal = "Molecular Cancer",
issn = "1476-4598",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System

AU - Belur, Lalitha

AU - Podetz-Pedersen, Kelly M.

AU - Sorenson, Brent S.

AU - Hsu, Alice H.

AU - Parker, Josh B.

AU - Carlson, Cathy S

AU - Saltzman, Daniel A

AU - Ramakrishnan, S.

AU - Mc Ivor, R S

PY - 2011/2/10

Y1 - 2011/2/10

N2 - Background: Metastatic colon cancer is one of the leading causes of cancer-related death worldwide, with disease progression and metastatic spread being closely associated with angiogenesis. We investigated whether an antiangiogenic gene transfer approach using the Sleeping Beauty (SB) transposon system could be used to inhibit growth of colorectal tumors metastatic to the liver.Results: Liver CT26 tumor-bearing mice were hydrodynamically injected with different doses of a plasmid containing a transposon encoding an angiostatin-endostatin fusion gene (Statin AE) along with varying amounts of SB transposase-encoding plasmid. Animals that were injected with a low dose (10 μg) of Statin AE transposon plasmid showed a significant decrease in tumor formation only when co-injected with SB transposase-encoding plasmid, while for animals injected with a higher dose (25 μg) of Statin AE transposon, co-injection of SB transposase-encoding plasmid did not significantly affect tumor load. For animals injected with 10 μg Statin AE transposon plasmid, the number of tumor nodules was inversely proportional to the amount of co-injected SB plasmid. Suppression of metastases was further evident in histological analyses, in which untreated animals showed higher levels of tumor cell proliferation and tumor vascularization than animals treated with low dose transposon plasmid.Conclusion: These results demonstrate that hepatic colorectal metastases can be reduced using antiangiogenic transposons, and provide evidence for the importance of the transposition process in mediating suppression of these tumors.

AB - Background: Metastatic colon cancer is one of the leading causes of cancer-related death worldwide, with disease progression and metastatic spread being closely associated with angiogenesis. We investigated whether an antiangiogenic gene transfer approach using the Sleeping Beauty (SB) transposon system could be used to inhibit growth of colorectal tumors metastatic to the liver.Results: Liver CT26 tumor-bearing mice were hydrodynamically injected with different doses of a plasmid containing a transposon encoding an angiostatin-endostatin fusion gene (Statin AE) along with varying amounts of SB transposase-encoding plasmid. Animals that were injected with a low dose (10 μg) of Statin AE transposon plasmid showed a significant decrease in tumor formation only when co-injected with SB transposase-encoding plasmid, while for animals injected with a higher dose (25 μg) of Statin AE transposon, co-injection of SB transposase-encoding plasmid did not significantly affect tumor load. For animals injected with 10 μg Statin AE transposon plasmid, the number of tumor nodules was inversely proportional to the amount of co-injected SB plasmid. Suppression of metastases was further evident in histological analyses, in which untreated animals showed higher levels of tumor cell proliferation and tumor vascularization than animals treated with low dose transposon plasmid.Conclusion: These results demonstrate that hepatic colorectal metastases can be reduced using antiangiogenic transposons, and provide evidence for the importance of the transposition process in mediating suppression of these tumors.

UR - http://www.scopus.com/inward/record.url?scp=79751526750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79751526750&partnerID=8YFLogxK

U2 - 10.1186/1476-4598-10-14

DO - 10.1186/1476-4598-10-14

M3 - Article

VL - 10

JO - Molecular Cancer

JF - Molecular Cancer

SN - 1476-4598

M1 - 14

ER -